Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Diabetic peripheral neuropathy |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
Have the security arrangements for your pharmacy been increased since the June pharmacy robbery/murders in Long Island?
• Yes
• Not yet, but plans are in the works
• We do not plan to increase security
|
|
|
Healthcare groups around the country are expressing concern about the announced merger of 2 of the biggest pharmacy benefit managers, Express Scripts and Medco Health Solutions.
Read full article. |
 |
|
|
To confirm your e-newsletter subscription, click here.
To ensure future delivery of email newsletters from
Drug Topics, please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
Bill Remak chairs the National Association for Hepatitis Task Forces and California Hepatitis C Task Force. The organizations he established for liver patients have grown into a
26-state network. |
Raw deal for pharmacists causes backlash for
liver patients. Read full article.
|
|
The National Community Pharmacists Association and Cardinal Health are encouraging female pharmacy students to consider community pharmacy ownership. Read full article.
|
|
CVS Caremark, the National Community Pharmacists Association, and several healthcare groups are supporting a new bill that would allow patients to purchase OTC medications through flexible spending accounts and health savings accounts. Read full article.
|
|
FDA has approved ticagrelor (Brilinta, AstraZeneca) tablets to reduce the rate of heart attack and cardiovascular death in adult patients with acute coronary syndrome. Read full article.
|
|
On June 15, 2011, FDA published an online safety communication informing prescribers and patients that pioglitazone (Actos, Takeda Pharmaceuticals America Inc.) use may be associated with a 20% to 40% increased hazard of new bladder cancer. Read full article.
|
|
FDA has approved the Risk Evaluation and Mitigation Strategy for Fentora (fentanyl buccal tablet)
[C-II] and Actiq (oral transmucosal fentanyl citrate) [C-II]. Both products, manufactured by Cephalon, are indicated for management of breakthrough pain in opioid-tolerant patients with cancer. Read full article.
 |
Meetings and Events
August 3-6, 2011 AADE Annual meeting and exhibition
Las Vegas
Contact:
800-338-3633 ext. 4878.
meetings@aadenet.org
August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
October 6-7, 2011 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
October 8-12 2011 NCPA Annual Convention
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
November 29, 2011 NACDS Foundation 13th Annual Dinner
New York, NY
Contact:
Jennifer Sargeant, Manager, Foundation Programs and Education, NACDS
703-837-4224
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
